Meetings

General Assembly Meeting (GA)
Type: meeting
Date: 10-11 June 2008
Place: Uppsala, Sweden
Objective/s: The meeting gave the possibility to plan the future ring trails activities for the last year of the project. Several chemicals have been selected to be tested in the various in vitro tests included in ReProTect and a final dossier, collecting the data generated, will be produced. The new implementation plan will be compiled according to the plans foreseen. In the General Assembly Meeting the state of the art of the project has been discussed and the formal procedures of the ring trails activities have been setting up in order to amend the Technical Annex of the project. Moreover, the integration of new partner tasks in WP1.1/2.2/4.4 has been and implemented.
Contact person: Prof. Michael Schwarz (P1)
Joint Research Area Meeting (JRAM)/General Assembly Meeting (GA)
Type: meeting
Date: 26-27 November 2007
Place: Ispra, Italy
Objective/s: The goal of the meeting was to give an overview about ReProTect's state of the art and to set the time schedule and plans for 2008. Moreover, the partners presented the results achieved and the future plans for of each Research. In addition, the meeting gave the possibility to discuss on how to proceed for establish a testing strategy/ies for reproductive toxicity testing. During the GA section the consortium voted for some contract modifications.
Contact person: Prof. Michael Schwarz (P1)
Joint Research Area Meeting (JRAM)/General Assembly Meeting (GA)
Type: meeting
Date: 11-12 June 2007
Place: Tuebingen, Germany
Objective/s: The goal of the meeting was to give an overview about ReProTect's state of the art, to give the partners the opportunity to present the results of each Research area and to discuss problems experienced in the last 6 months. In addition, the meeting gave the possibility to set the time schedule and plans for 2007.
Joint Research Area Meeting (JRAM)/General Assembly Meeting (GA)
Type: meeting
Date: 4-5 December 2006
Place: Ispra, Italy
Objective/s: The General Assembly meeting was held in order to vote for some amendments of the contract. Furthermore, the goal of the meeting was to give an overview about ReProTect's state of the art, to give the partners the opportunity to present the results of each Research area and to discuss problems experienced in the last 6 months. In addition, the meeting gave the possibility to set the time schedule for 2006.
Contact person: Prof. Michael Schwarz (P1)
ED prevalidation Meeting
Type: meeting
Date: 7 September 2006
Place: Ispra, Italy
Objective/s: The meeting was held in order to give an overview of the progress in the prevalidation of three Endocrine Disruptors in vitro systems being validated within ReProTect. The partners had the opportunity to present their most recent results and discuss problems experienced during the last two years, as well as plan for the future validation work. In addition, the meeting provided the opportunity to set and remind the partners of the time schedule for the future.
Contact person: Susanne Bremer (P35)
Joint Research Area Meeting/General Assembly Meeting (GA)
Type: meeting
Date: 29-30 May 2006
Place: Orvieto, Italy
Objective/s: the meeting was held in order to vote for the new partners that will join the project in workpackage II 'Implantation'. Furthermore, the goal of the meeting was to give an overview about ReProTect's state of the art, to give the partners the opportunity to present the results of each Research area and to discuss problems experienced in the last 6 months and to vote regarding some contract modifications. Another aim of the meeting was to give guidelines for the second periodic activity report and to present the new ReProTect webpage. In addition, the meeting gave the possibility to set and to remind the time schedule for 2006.
Contact person: Prof. Michael Schwarz (P1)
General Assembly Meeting (GA)
Type: meeting
Date: 5-6 December 2005
Place: Vienna, Austria
Objective/s: As mentioned in Annex I the GA aims to select new partners that will join the project. Furthermore, the goal of the meeting was to give an overview about ReProTect's state of the art, to give the partners the opportunity to present the results of each Research area and to discuss problems experienced in the last 6 months and to vote regarding some contract modifications. Another aim of the meeting was to give guidelines for the second interim report and discuss the outcome of the previous periodic activity report (first 12 months). In addition, the meeting gave the possibility to set and to remind the time schedule for 2006.
Contact person: Prof. Michael Schwarz (P1)
Joint Research Area meeting (JRAM)
Type: meeting
Date: 31 May and 1 June 2005
Place: Ispra, Italy
Objective/s: the goal of the meeting was to give to the partners the opportunity to present the results of each Research area and to discuss problems experienced in the first 12 months. Another aim of the meeting was to clarify doubts regarding the first 12 months report (financial and scientific) and explain the outcome results of the previous Sensor technologies workshop (held in Ispra, 3-4 May 2005). In addition, the meeting gave the possibility to fix and to remind the time schedule until the end of 2005.
Contact person: Prof. Michael Schwarz (P1)
Joint Research Area meeting (JRAM)
Type: meeting
Date: 18-19 January 2005
Place: Copenhagen, Denmark
Objective/s: the principal goal of the meeting was to give an overview about ReProTect's state of the art, to give the partners the opportunity to present results in each Research area and to discuss problems experienced in the first 6 months. The meeting was also held to clarify and decide about amendments of the Contract and the Consortium Agreement. In addition, the meeting gave the possibility to fix the time schedule for 2005.
Contact person: Prof. Michael Schwarz (P1)
Kick-off Meeting
Type: meeting
Date: 19-21 July 2004
Place: Ispra, Italy
Objective/s: the kick-off meeting was the first general assembly which was a scientific forum for discussion and it ensured that the participants will have the same level of knowledge concerning the requirements of an alternative method for animal experiments.
Contact person: Prof. Michael Schwarz (P1)